Rates of one type of breast cancer — invasive lobular carcinoma — have been rising in the United States more than three times faster than those of all other breast cancers combined over the past ...

A recent study found that breast cancer–specific survival in patients with invasive lobular carcinoma was inferior compared to patients with invasive ductal carcinoma. A recent study found that breast ...

While the ductal subtype accounts for 70% to 80% of all breast cancers and the lobular subtype accounts for just 10% to 15%, the lobular subtype is more common among peri- and postmenopausal women, is ...

Herein we report the case of an elderly gentleman diagnosed with the pleomorphic variant of invasive lobular carcinoma along with involvement of the ipsilateral axillary lymph nodes. Only three cases ...

Lobular breast cancer rates increased 2.8 percent per year over the past decade, compared with a 0.8 percent annual increase for all other breast cancers. Lobular breast cancer grows in a linear ...

Women with estrogen receptor (ER)–positive, human epidermal growth factor receptor 2 (HER2)–negative invasive lobular carcinoma who are treated with endocrine therapy do not derive any additional ...

While researchers work to improve lobular breast cancer screening, innovative treatments are improving outcomes for patients with the condition, which is diagnosed in more than 40,000 Americans each ...

TUESDAY, Oct. 14, 2025 (HealthDay News) -- The incidence rates for invasive lobular carcinoma (ILC) increased from 2012 to 2021 for all racial and ethnic groups, according to a study published online ...